The company is selling its applied, food, and enterprise services to New Mountain Capital for $2.45 billion in cash.
Quest Diagnostics Sells its Share of Q2 Solutions to Iqvia for $760M
Iqvia and Quest established Q2 solutions, originally known as Quintiles Research, as a joint venture in 2015 with Quest owning 40 percent of the firm.
Novacyt to Sell Cytology, Clinical Lab Units
The company said it will sell off the businesses in order to focus on in vitro diagnostic product development and its diagnostic reagent units.
Rosetta Genomics Inks Deal to Sell PersonalizeDx for $2.9M
Rosetta acquired PersonalizeDx and its range of molecular diagnostic offerings in early 2015 for $2 million in cash plus stock.
Hologic Completes Divestiture of Grifols for $1.85B
Hologic's CEO said in December that the blood screening business was a drag on the company's growth.